TCON Margin operasi TRACON Pharmaceuticals

TCON (TRACON Pharmaceuticals Inc.) - tandha merek perusahaan

A total collapse following failed tests led to the liquidation of TRACON Pharmaceuticals (TCON) assets. The operating income ratio on GURU.Markets visualizes this decline, where the value 0.00 shows the current magnitude. Previously, the business relied on the development of oncology drugs and antibodies for tumor therapy. Capitalization was based on royalties and upfront payments from partners treating rare forms of cancer.

TCON: Rentabilitas dodolan operasi TRACON Pharmaceuticals Inc. 04.07.2022 - 04.08.2024

Rincian metrik keuangan lan pasar TRACON Pharmaceuticals (TCON)

Analisis wiwitan perusahaan:TRACON Pharmaceuticals, Inc, TCON
Produk merek TRACON Pharmaceuticals, Inc

For the biopharmaceutical sector of TRACON Pharmaceuticals (TCON), which is characterized by a lack of stable sales and a dependence on external capital, the operating margin serves as a critical indicator of cost control. When analyzing the level of operational efficiency, an investor assesses the ratio of operating profit to revenue, where sharp fluctuations in the curve often signal temporary spikes in efficiency followed by a reversion to the mean.

Analisis perusahaan pesaing

Margin dodolan operasi TEM|QGEN - Tingkat bathi adhedhasar bathi operasi|Margin operasi IONS|RGEN - Rentabilitas dodolan operasi|Rentabilitas operasi Avidity RNA|Margin operasi CRISPR Therapeutics Corp CRSP|GeneDx Corp - Margin operasi|Ultragenyx Pharma (RARE) - Margin dodolan operasi|beamtx.com (BEAM) - Rentabilitas operasi|SRPT: Rasio bathi operasi|Margin dodolan operasi TWST|TXG - Tingkat bathi adhedhasar bathi operasi|Margin operasi NTLA|Rentabilitas kegiatan operasi Stoke Therapeutics|Rentabilitas operasi BioLife Solutions BLFS|Wave Life Sciences (WVE) - Rentabilitas dodolan operasi|Maze Therapeutics, Inc. - Margin operasi|Rentabilitas kegiatan operasi Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Rentabilitas operasi|TSHA: Rasio bathi operasi|Rentabilitas operasi uniQure Pharma|MGTX - Tingkat bathi adhedhasar bathi operasi|Margin operasi RGNX|Rentabilitas operasi SLDB (Solid Biosciences)|Ocugen Corp - Margin dodolan operasi|PACB: Rentabilitas dodolan miturut bathi operasi|benitec.com - Margin operasi|DSGN - Margin operasi|RCKT: Margin operasi|FDMT (4D Molecular Therapeutics Inc) - Rentabilitas operasi|Margin dodolan operasi LXEO|Rentabilitas operasi KRRO|Margin operasi EDIT|SLN - Rentabilitas dodolan operasi|Margin operasi PRQR (ProQR)|CDXS - Margin dodolan operasi|Sangamo Therapeutics Inc. - Margin operasi|NAUT - Margin operasi|MGX: Margin operasi|Margin dodolan operasi Precision BioSciences, Inc.|GBIO (Generation Bio) - Margin operasi|Boundless Bio Inc. (BOLD) - Rentabilitas kegiatan operasi|Margin dodolan operasi XCUR (exicuretx.com)|Imunon Inc - Rentabilitas dodolan miturut bathi operasi|Margin operasi PHIO (Phio Pharmaceuticals Corp)|Tingkat bathi operasi MBIO|RNAZ - Rentabilitas operasi|Tingkat bathi operasi BNGO (bionanogenomics.com)|Applied DNA Sciences (APDN) - Rentabilitas operasi|Bluebird Bio - Tingkat bathi operasi|IPA (ImmunoPrecise Antibodies Ltd) - Margin operasi|Rentabilitas dodolan operasi Omega Therapeutics, Inc. OMGA|Margin operasi OMIC|RGLS (Regulus Therapeutics Inc.) - Tingkat bathi operasi|Margin operasi SYRS (Syros Pharmaceuticals Inc.)|Rasio bathi operasi TBIO (Codex DNA)|UBX - Rentabilitas operasi